bioRxivGenomicsPreprint
Multimodal functional characterization of the LDLR noncoding landscape
Hitarthi VyasiD, Kyle LeixiD, Bala Bharathi BurugulaiD, Sanjana M. PayeiD, Chinmay RautiD, Elizabeth K. SpeliotesiD, Brian T. EmmeriD
- Citations
- 0
Abstract
The expression level of the low-density lipoprotein receptor (LDLR) gene is a critical determinant of circulating low-density lipoprotein concentrations and the corresponding risk of atherosclerotic cardiovascular disease. While the importance of sterol response elements in LDLR transcriptional regulation has been firmly established, the functional contribution of other potential cis-regulatory elements (CREs) remains poorly understood. In this study, we developed and applied a variety of high throughput functional genomic tools to systematically interrogate the noncoding space at the LDLR locus. These included saturation CRISPR nuclease, CRISPR activation, and CRISPR inhibition screening as well as a massively parallel reporter assay. With each approach, we observed robust discrimination of control sequences and significant effects for other regions with a previously unrecognized influence on LDLR expression. The CREs identified by each modality were overlapping but distinct, both in relation to each other and to those regions predicted to harbor CRE activity. Collectively, our findings clarify the functional landscape of the LDLR locus and highlight the complementary nature of different functional genomic approaches to CRE identification.
- organism: human
- assay: CRISPR screen
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional interrogation of candidate cis-regulatory elements at the LDLR locus
Kyle Leix, Candilianne Serrano-Zayas, … Brian T. Emmer·bioRxiv·Mar 20, 2025
- CSDE1 is a Post-Transcriptional Regulator of the LDL Receptor
Geoffrey A. Smith, Arun Padmanabhan, … John S. Chorba·Science Translational MedicinePeer-reviewed·Sep 14, 2022
- Genome-scale CRISPR screening for modifiers of cellular LDL uptake
Brian T. Emmer, Emily J. Sherman, … David Ginsburg·PLoS GeneticsPeer-reviewed·Jan 29, 2021
- Regulation of cellular LDL uptake by PROX1 and CHD7
Candilianne Serrano-Zayas, Matthew L. Holding, … Brian T. Emmer·bioRxiv·Sep 20, 2022
- GOLIATH regulates LDLR availability and plasma LDL cholesterol levels
Bethan L. Clifford, Kelsey E. Jarrett, … Elizabeth J. Tarling·bioRxiv·Dec 9, 2020
- Transgelin: A New Gene Involved in LDL Endocytosis Identified by a Genome-wide CRISPR-Cas9 Screen
D. Lucero, O. Dikilitas, … A. T. Remaley·bioRxiv·Dec 23, 2020